Physician profile
Christopher M Corsi
NPI 1174577589
$977.76
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $240 · 2021: $42.92 · 2023: $73.58 · 2024: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $188.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $258.57 | 2019-2024 | Evenity |
| Senseonics, Incorporated | $102.00 | 2019 | |
| Radius Health, INC. | $80.00 | 2019-2020 | |
| Dexcom, INC. | $69.33 | 2020-2023 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.61 | 2019-2020 | |
| Novo Nordisk INC | $57.84 | 2019 | |
| Lilly USA, LLC | $56.90 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $51.85 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Recordati_rare_diseases_inc. | $46.06 | 2020 | |
| Abbott Laboratories | $33.96 | 2020-2021 | |
| Horizon Therapeutics Plc | $29.76 | 2023 | Tepezza |
| Merck Sharp & Dohme LLC | $28.54 | 2019-2020 | |
| Abbvie INC. | $16.16 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $15.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.78 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $13.50 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.46 | 2019 | |
| Medtronic, INC. | $13.31 | 2023 | Minimed 780g |
| Corcept Therapeutics | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Corsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.